CHRISTINA PEACOCK: Open Payments
NPI 1689031411 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 32 payments from 15 companies in 2025. Trend: 2023 $1,059 · 2024 $1,528 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $76 |
| Novo Nordisk Inc | 4 | $72 |
| Lilly USA, LLC | 3 | $61 |
| Amgen Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Abbott Laboratories | 3 | $49 |
| PFIZER INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Grifols USA, LLC | 1 | $26 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, Ozempic, BREZTRI, Rybelsus, TRELEGY ELLIPTA, VRAYLAR, OTEZLA.
Industry payments across NC — which companies pay providers there.
